Judges Mull Whether Word 'Random' Kills Bayer Patent Win
Law360 (August 31, 2020, 8:12 PM EDT) -- Federal Circuit judges looked hard Monday at whether a Delaware jury mistakenly leaned on the word "random" when deciding last year that a Takeda unit had infringed Bayer's rights to a hemophilia treatment, leading to a $155 million patent infringement verdict.
Baxalta Inc. took its case to the appeals court because it contended that a federal judge had erred by coming up with his own construction of the patent held by Bayer Healthcare LLC, and then neglecting to explain what he meant to the jury. The patent covers a series of hemophilia medications, including Bayer's Kogenate, Kogenate FS and Kovaltry.
Baxalta's development of its...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!